tyramine has been researched along with selegiline in 69 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 40 (57.97) | 18.7374 |
1990's | 10 (14.49) | 18.2507 |
2000's | 11 (15.94) | 29.6817 |
2010's | 7 (10.14) | 24.3611 |
2020's | 1 (1.45) | 2.80 |
Authors | Studies |
---|---|
Alcaro, S; Bolasco, A; Cardia, MC; Distinto, S; Gaspari, M; Kirchmair, J; Maccioni, E; Markt, P; Meleddu, R; Ortuso, F; Sanna, ML; Secci, D; Wolber, G; Yáñez, M | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Kung, HC; Wilson, AG | 1 |
Cross, AJ; Glover, V; Lofthouse, R; Owen, F | 1 |
Guha, SR; Mitra, C | 1 |
Boulton, AA; Philips, SR | 1 |
Ashford, A; Glover, V; Sandler, M; Stern, GM | 1 |
Lees, AJ; Sandler, M; Stern, GM | 1 |
Jánváriné Kanyó, E; Tardos, L | 1 |
Abdo-Rubo, A | 1 |
Bunag, RD; Kerecsen, L | 1 |
Antonin, KH; Bieck, PR; Hoffmann, E; Jedrychowski, M; Nilsson, E; Schick, C; Schulz, R | 1 |
Bonetti, EP; Da Prada, M; Imhof, R; Keller, HH; Kettler, R | 1 |
Al Mousawi, M; Glover, V; Pare, CM; Sandler, M | 1 |
Youdim, MB | 2 |
Andrada, MC; Cabanillas, AM; Coleoni, AH; Masini-Repiso, AM | 1 |
Finberg, JP; Youdim, MB | 2 |
Glover, V; Goodwin, BL; Prasad, A; Sandler, M; Signy, M; Smith, SE | 1 |
Cohen, RM; Jimerson, DC; Mueller, EA; Murphy, DL; Pickar, D; Sunderland, T | 1 |
Fozard, JR; Palfreyman, MG; Robin, M; Zreika, M | 1 |
Radwan, M; Wijsenbeek, H; Zemishlany, Z | 1 |
Cohen, RM; Garrick, NA; Karoum, F; Linnoila, M; Murphy, DL; Roy, B; Siever, LJ; Wyatt, RJ | 1 |
Severina, IS | 1 |
Glover, V; Pycock, CJ; Sandler, M | 1 |
Sandler, M | 2 |
Aarons, SF; Brown, RD; Frances, AJ; Mann, JJ | 1 |
Egashira, T; Yamamoto, T; Yamanaka, Y | 1 |
Da Prada, M; Haefely, WE; Keller, HH; Kettler, R; Pieri, L | 1 |
Ohishi, N; Sato, M; Yagi, K | 1 |
Asano, M; Hattori, H; Katsumata, Y; Oya, M; Suzuki, O | 1 |
Ashford, A; Esmail, A; Glover, V; Sandler, M | 1 |
Arai, Y; Kamijo, K; Kinemuchi, H; Wakui, Y | 1 |
Garrick, NA; Murphy, DL | 1 |
Glover, V; Mendis, N; Pare, CM; Sandler, M; Stern, GM | 1 |
Deverina, IS | 1 |
Azzaro, AJ; Schoepp, DD | 1 |
Kamijo, K; Kobayashi, S; Oguchi, K; Uesato, T | 1 |
Finberg, JP; Tenne, M; Youdim, MB | 1 |
Calne, DB; Chuang, LW; Eisler, T; Karoum, F; Klein, DF; Liebowitz, MR; Quitkin, FM; Wyatt, RJ | 1 |
Dénes, B; Greeff, K; Tawfik, H | 1 |
Anderson, MC; Hasan, F; McCrodden, JM; Tipton, KF | 1 |
Dingemanse, J; Korn, A; Moritz, E; Wagner, B | 1 |
Ekblom, J; Lu, G; Oreland, L; Owera-Atepo, JB; Shih, JC; Unge, T | 1 |
Azzaro, AJ; Barrett, JS; Darnow, J; DeWitt, KE; DiSanto, AR; Hochadel, TJ; Morales, RJ; Rohatagi, S; Watson, SK | 1 |
Cohen, RM; Karoum, F; Lipper, S; Mellow, AM; Murphy, DL; Pickar, D; Sunderland, T; Tariot, PN | 1 |
Chouinard, S; Fahn, S | 1 |
Bitsios, P; Bradshaw, CM; Langley, RW; Pyykkö, K; Scheinin, M; Szabadi, E; Tavernor, S | 1 |
Knoll, B; Knoll, J; Miklya, I; Moto, T; Ohde, H; Sakae, M; Yoneda, F | 1 |
Gorodetsky, E; Gross, A; Wang, RH; Weinreb, O; Weinstock, M; Youdim, MB | 1 |
Amsterdam, JD | 1 |
Boyce, M; Clarke, A; Corn, TH; Johnson, ES; Johnston, A; MacMahon, DG; Mallard, N; Warrington, S | 1 |
Shimazu, S; Takahata, K; Yoneda, F | 1 |
Riederer, PF; Youdim, MB | 1 |
Bryla, J; Chodnicka, K; Doroszewska, R; Drozak, J; Winiarska, K | 1 |
Preskorn, SH | 1 |
Azzaro, AJ; Blob, LF; Campbell, BJ; Kemper, EM; Oren, DA; Sharoky, M; Vandenberg, CM | 1 |
Azzaro, AJ; Blob, LF; Campbell, BJ; Gilmor, MG; Kemper, EM; Sharoky, M; VanDenberg, CM | 1 |
Tobin, M | 1 |
Adar, L; Goren, T; Sasson, N; Weiss, YM | 1 |
Kostenko, O; Malone, D; Wimbiscus, M | 1 |
Bodkin, JA; Pae, CU; Patkar, AA; Portland, KB; Thase, ME | 1 |
Goldberg, JF; Thase, ME | 1 |
Fontenla, JA; Friedman, C; Gonzalez-Franco, RM; Matos, MJ; Santana, L; Tatonetti, NP; Uriarte, E; Vilar, S; Viña, D | 1 |
Legoabe, LJ; Meiring, L; Petzer, A; Petzer, JP | 1 |
7 review(s) available for tyramine and selegiline
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacology of MAO B inhibitors: mode of action of (-)deprenyl in Parkinson's disease.
Topics: Animals; Brain; Dopamine; Drug Therapy, Combination; Humans; Levodopa; Monoamine Oxidase; Parkinson Disease; Phenethylamines; Selegiline; Serotonin; Tyramine | 1986 |
Monoamine oxidase inhibitors--current status.
Topics: Antidepressive Agents, Tricyclic; Brain Chemistry; Catecholamines; Chemical Phenomena; Chemistry; Clorgyline; Depressive Disorder; Drug Interactions; Humans; Hydrazines; Hypertension; Kinetics; Monoamine Oxidase Inhibitors; Phobic Disorders; Receptors, Adrenergic; Receptors, Serotonin; Selegiline; Tyramine | 1983 |
The pharmacology of Parkinson's disease: basic aspects and recent advances.
Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Bromocriptine; Carbidopa; Corpus Striatum; Dopamine; Ergolines; Humans; Kidney; Kinetics; Levodopa; Lisuride; Liver; Methyldopa; Norepinephrine; Parkinson Disease; Pergolide; Receptors, Dopamine; Selegiline; Serotonin; Stereotyped Behavior; Substantia Nigra; Tyramine | 1984 |
The advent of selective monoamine oxidase A inhibitor antidepressants devoid of the cheese reaction.
Topics: Benzamides; Cheese; Clorgyline; Depressive Disorder; Humans; Hypertension; Moclobemide; Monoamine Oxidase Inhibitors; Selegiline; Tyramine | 1995 |
A review of the mechanisms and role of monoamine oxidase inhibitors in Parkinson's disease.
Topics: Adolescent; Adult; Aged; Antiparkinson Agents; Basal Ganglia; Cheese; Child; Child, Preschool; Dopamine; Drug Design; Humans; Hypertension; Infant; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Neurotransmitter Agents; Parkinson Disease; Selegiline; Tyramine | 2004 |
MAO inhibitors: risks, benefits, and lore.
Topics: Administration, Cutaneous; Antidepressive Agents; Blood Pressure; Cheese; Depressive Disorder, Major; Feeding Behavior; Food-Drug Interactions; Humans; Hypertension; Monoamine Oxidase Inhibitors; Myocardium; Risk Factors; Selegiline; Tyramine | 2010 |
14 trial(s) available for tyramine and selegiline
Article | Year |
---|---|
Tyramine pressor sensitivity changes during deprenyl treatment.
Topics: Blood Pressure; Dose-Response Relationship, Drug; Humans; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Phenethylamines; Selegiline; Tyramine | 1985 |
Clinical efficacy of deprenyl, a specific inhibitor of MAOB.
Topics: Adrenocorticotropic Hormone; Adult; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Humans; Middle Aged; Monoamine Oxidase Inhibitors; Mood Disorders; Phenethylamines; Pituitary Gland, Anterior; Receptors, Muscarinic; Selegiline; Tyramine | 1983 |
Studies of selective and reversible monoamine oxidase inhibitors.
Topics: Animals; Benzamides; Blood Platelets; Brain; Clinical Trials as Topic; Depressive Disorder; Dopamine; Double-Blind Method; Drug Interactions; Food; Humans; Male; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Panic; Phenethylamines; Phobic Disorders; Rats; Selegiline; Serotonin; Tyramine | 1984 |
Is the failure of (-)deprenyl, a selective monoamine oxidase B inhibitor, to alleviate depression related to freedom from the cheese effect?
Topics: Blood Pressure; Cheese; Depressive Disorder; Double-Blind Method; Drug Interactions; Female; Humans; Male; Phenethylamines; Placebos; Selegiline; Tyramine | 1981 |
Tyramine pressor sensitivity in healthy subjects during combined treatment with moclobemide and selegiline.
Topics: Adrenergic Agents; Adult; Analysis of Variance; Benzamides; Blood Pressure; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Food-Drug Interactions; Humans; Hypertension; Injections, Intravenous; Male; Moclobemide; Monoamine Oxidase Inhibitors; Selegiline; Tyramine | 1996 |
Pressor response to tyramine after single 24-hour application of a selegiline transdermal system in healthy males.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Humans; Male; Monoamine Oxidase Inhibitors; Selegiline; Single-Blind Method; Tyramine | 1997 |
Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline).
Topics: Biogenic Amines; Chromosome Deletion; Clorgyline; Depressive Disorder; Humans; Isoenzymes; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Phenethylamines; Reference Values; Retrospective Studies; Selegiline; Tyramine; X Chromosome | 1998 |
Experience with tranylcypromine in early Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Depression; Erectile Dysfunction; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline; Sleep Initiation and Maintenance Disorders; Time Factors; Tranylcypromine; Tyramine | 1998 |
Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man.
Topics: Adult; Analysis of Variance; Benzamides; Blood Platelets; Double-Blind Method; Drug Interactions; Feasibility Studies; Humans; Male; Meiosis; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Naphthols; Propylene Glycols; Pupil; Selegiline; Tyramine | 1998 |
A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder.
Topics: Administration, Cutaneous; Adult; Aged; Ambulatory Care; Depressive Disorder; Diet; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Monoamine Oxidase Inhibitors; Placebos; Psychiatric Status Rating Scales; Selegiline; Treatment Outcome; Tyramine | 2003 |
A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition.
Topics: Administration, Oral; Adult; Aged; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Patient Satisfaction; Reference Values; Selegiline; Treatment Outcome; Tyramine | 2003 |
Tyramine pressor sensitivity during treatment with the selegiline transdermal system 6 mg/24 h in healthy subjects.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Food-Drug Interactions; Heart Rate; Humans; Hypertension; Male; Middle Aged; Monoamine Oxidase Inhibitors; Reference Values; Selegiline; Time Factors; Tranylcypromine; Tyramine | 2006 |
Effects of a tyramine-enriched meal on blood pressure response in healthy male volunteers treated with selegiline transdermal system 6 mg/24 hour.
Topics: Administration, Cutaneous; Adolescent; Adult; Blood Pressure; Cheese; Double-Blind Method; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Selegiline; Tyramine | 2007 |
Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline.
Topics: Adult; Aged; Algorithms; Contraindications; Diet; Dose-Response Relationship, Drug; Double-Blind Method; Drug Labeling; Female; Humans; Hypertension; Indans; Isoenzymes; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline; Tyramine; United States | 2010 |
48 other study(ies) available for tyramine and selegiline
Article | Year |
---|---|
Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B.
Topics: Binding Sites; Humans; Hydrazones; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Dynamics Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Protein Conformation; Structure-Activity Relationship; Tandem Mass Spectrometry; Thiazoles | 2012 |
Characterization of rat pulmonary monoamine oxidase.
Topics: Animals; Clorgyline; Kinetics; Lung; Male; Monoamine Oxidase; Oxidation-Reduction; Phenethylamines; Rats; Selegiline; Serotonin; Substrate Specificity; Tyramine | 1979 |
Distribution and inhibition characteristics of human brain monoamine oxidase.
Topics: Aged; Benzylamines; Brain; Clorgyline; Dopamine; Female; Humans; In Vitro Techniques; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Selegiline; Serotonin; Substrate Specificity; Tyramine | 1979 |
Inhibition patterns of monoamine oxidase in sub-fractions of rat brain mitochondria in presence of some selective inhibitors.
Topics: Animals; Brain; Harmaline; Harmine; In Vitro Techniques; Male; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Rats; Selegiline; Serotonin; Substrate Specificity; Tyramine | 1979 |
The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.
Topics: Amines; Animals; Clorgyline; Corpus Striatum; Iproniazid; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Phenethylamines; Rats; Selegiline; Tranylcypromine; Tryptamines; Tyramine | 1979 |
Absence of "cheese effect" during deprenyl therapy: some recent studies.
Topics: Amphetamines; Animals; Blood Pressure; Humans; Intestines; Monoamine Oxidase; Parkinson Disease; Phenethylamines; Selegiline; Substrate Specificity; Swine; Tyramine | 1978 |
Recent observations on the clinical pharmacology of (-)deprenyl.
Topics: Adult; Aged; Blood Pressure; Drug Therapy, Combination; Heart Rate; Humans; Levodopa; Middle Aged; Parkinson Disease; Phenethylamines; Selegiline; Time Factors; Tyramine | 1978 |
[Pharmacology of selegiline (recent considerations)].
Topics: Age Factors; Animals; Dose-Response Relationship, Drug; Mice; Neurotransmitter Uptake Inhibitors; Rats; Selegiline; Sexual Behavior, Animal; Tyramine | 1992 |
The effect of various monoamine oxidase (MAO) inhibitors on the response of blood pressure of rats and cats to tyramine.
Topics: Anesthesia; Animals; Blood Pressure; Cats; Dose-Response Relationship, Drug; Monoamine Oxidase Inhibitors; Rats; Selegiline; Tyramine | 1990 |
Selective pressor enhancement by monoamine oxidase inhibitors in conscious rats.
Topics: Animals; Blood Pressure; Clorgyline; Heart Rate; Male; Monoamine Oxidase Inhibitors; Phenylephrine; Rats; Rats, Inbred Strains; Selegiline; Tyramine | 1989 |
Tyramine kinetics and pressor sensitivity during monoamine oxidase inhibition by selegiline.
Topics: Administration, Oral; Adult; Amphetamine; Blood Pressure; Chromatography, Gas; Double-Blind Method; Electrocardiography; Female; Humans; Injections, Intravenous; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Phenethylamines; Phenylacetates; Random Allocation; Selegiline; Tyramine | 1989 |
Ro 16-6491: a new reversible and highly selective MAO-B inhibitor protects mice from the dopaminergic neurotoxicity of MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzamides; Brain; Corpus Striatum; Dopamine; Male; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease, Secondary; Pyridines; Rats; Selegiline; Substantia Nigra; Tyramine | 1987 |
Attempts to attenuate the 'cheese effect'. Combined drug therapy in depressive illness.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Monoamine Oxidase Inhibitors; Phenethylamines; Selegiline; Tyramine | 1985 |
Monoamine oxidase in bovine thyroid tissue.
Topics: Animals; Biogenic Amines; Cattle; Clorgyline; Monoamine Oxidase; Phenethylamines; Selegiline; Serotonin; Subcellular Fractions; Substrate Specificity; Thyroid Gland; Tyramine | 1986 |
MAO type B inhibitors as adjunct to L-dopa therapy.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alkynes; Animals; Brain; Drug Therapy, Combination; Humans; Indans; Isoenzymes; Levodopa; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Receptors, Dopamine; Selegiline; Structure-Activity Relationship; Tyramine | 1987 |
Enhanced pressor sensitivity to oral tyramine challenge following high dose selegiline treatment.
Topics: Adult; Blood Platelets; Blood Pressure; Female; Humans; Male; Methoxyhydroxyphenylglycol; Phenethylamines; Pulse; Selegiline; Tyramine | 1988 |
Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat.
Topics: Amines; Animals; Blood Pressure; Brain; Cats; Clorgyline; Female; Indans; Liver; Male; Monoamine Oxidase Inhibitors; Nictitating Membrane; Phenethylamines; Selegiline; Sympathetic Nervous System; Tyramine | 1985 |
The functional consequences of inhibition of monoamine oxidase type B: comparison of the pharmacological properties of L-deprenyl and MDL 72145.
Topics: Allylamine; Amines; Animals; Body Temperature; Brain; Electric Stimulation; Hemodynamics; Hydroxydopamines; Male; Mice; Monoamine Oxidase Inhibitors; Motor Activity; Norepinephrine; Oxidopamine; Phenethylamines; Rats; Rats, Inbred Strains; Reserpine; Selegiline; Spinal Cord; Sympathectomy, Chemical; Sympathetic Nervous System; Tyramine | 1985 |
Clinical and laboratory studies with selective monoamine-oxidase-inhibiting drugs. Implications for hypothesized neurotransmitter changes associated with depression and antidepressant drug effects.
Topics: Behavior; Biogenic Amines; Clorgyline; Depressive Disorder; Dopamine; Histamine; Humans; Monoamine Oxidase Inhibitors; Norepinephrine; Pargyline; Phenethylamines; Selegiline; Serotonin; Tyramine | 1983 |
[Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
Topics: Animals; Clorgyline; Dose-Response Relationship, Drug; Kinetics; Male; Mitochondria, Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenethylamines; Propylamines; Protein Denaturation; Rats; Selegiline; Serotonin; Tyramine; Urea | 1983 |
Tyramine and depressive illness.
Topics: Animals; Clorgyline; Depressive Disorder; Humans; Phenotype; Rats; Selegiline; Tyramine | 1983 |
Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.
Topics: Animals; Cerebral Cortex; Clorgyline; Drug Interactions; Female; In Vitro Techniques; Male; Monoamine Oxidase Inhibitors; Norepinephrine; Phenethylamines; Rats; Selegiline; Stereoisomerism; Tritium; Tyramine | 1983 |
Monoamine oxidase inhibitors and their pharmacological significance.
Topics: Animals; Antidepressive Agents; Brain; Clorgyline; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Phenethylamines; Rats; Selegiline; Tyramine | 1983 |
Characteristics of mitochondrial and synaptosomal monoamine oxidase in monkey brain.
Topics: Animals; Brain; Cattle; Clorgyline; Guinea Pigs; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Macaca; Mice; Mitochondria; Monoamine Oxidase; Nerve Tissue Proteins; Phenethylamines; Rabbits; Rats; Selegiline; Serotonin; Species Specificity; Substrate Specificity; Synaptosomes; Tyramine | 1984 |
Localization and identification of covalently bound flavoproteins in rat liver mitochondria by prelabeling of their flavin moiety.
Topics: Animals; Benzylamines; Carbon Radioisotopes; Clorgyline; Flavoproteins; Male; Mitochondria, Liver; Molecular Weight; Monoamine Oxidase; Oxidoreductases, N-Demethylating; Pargyline; Protein Binding; Rats; Rats, Inbred Strains; Riboflavin; Sarcosine Dehydrogenase; Selegiline; Serotonin; Tritium; Tyramine | 1984 |
Inhibition of monoamine oxidase by d-methamphetamine.
Topics: Animals; Brain; Clorgyline; In Vitro Techniques; Kinetics; Male; Methamphetamine; Mitochondria; Monoamine Oxidase Inhibitors; Phenethylamines; Rats; Selegiline; Serotonin; Tyramine | 1980 |
The inhibition of tyramine oxidation and the tyramine hypertensive response ("cheese effect") may be independent phenomena.
Topics: Animals; Blood Pressure; Clorgyline; Hypertension; Liver; Male; Monoamine Oxidase; Phenethylamines; Propylamines; Selegiline; Swine; Tissue Distribution; Tyramine | 1980 |
Inhibition of monoamine oxidase by clorgyline and deprenyl in circumventricular structures of rat brain.
Topics: Animals; Brain; Cerebral Ventricles; Clorgyline; In Vitro Techniques; Male; Monoamine Oxidase Inhibitors; Phenethylamines; Propylamines; Rats; Selegiline; Serotonin; Tyramine | 1980 |
Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain.
Topics: Animals; Brain; Caudate Nucleus; Cerebral Cortex; Chlorocebus aethiops; Clorgyline; Deamination; Dopamine; Female; Humans; Macaca mulatta; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Phenethylamines; Rats; Selegiline; Serotonin; Species Specificity; Substrate Specificity; Tyramine | 1980 |
[Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
Topics: Animals; Binding, Competitive; Clorgyline; Enzyme Activation; Kinetics; Male; Mitochondria, Liver; Monoamine Oxidase Inhibitors; Phenethylamines; Propylamines; Protein Binding; Rats; Selegiline; Tyramine | 1980 |
Specificity of endogenous substrates for types A and B monoamine oxidase in rat striatum.
Topics: Animals; Clorgyline; Corpus Striatum; Dopamine; Isoenzymes; Kinetics; Male; Monoamine Oxidase; Phenethylamines; Rats; Selegiline; Serotonin; Substrate Specificity; Tyramine | 1981 |
Studies on beta-phenylethylamine deamination by human placental monoamine oxidase.
Topics: Deamination; Female; Humans; Kinetics; Monoamine Oxidase; Phenethylamines; Placenta; Pregnancy; Selegiline; Serotonin; Tyramine | 1981 |
Monoamine oxidase inhibitor efficacy in depression and the "cheese effect".
Topics: Animals; Blood Pressure; Cheese; Depressive Disorder; Humans; Monoamine Oxidase Inhibitors; Norepinephrine; Selegiline; Tyramine | 1981 |
Tyramine antagonistic properties of AGN 1135, an irreversible inhibitor of monoamine oxidase type B.
Topics: Animals; Blood Pressure; Clorgyline; In Vitro Techniques; Indans; Indenes; Male; Metaraminol; Monoamine Oxidase Inhibitors; Neurons; Octopamine; Rats; Selegiline; Tyramine; Vas Deferens | 1981 |
Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Amphetamines; Biogenic Amines; Carbidopa; Depression; Drug Combinations; Female; Humans; Levodopa; Male; Methamphetamine; Middle Aged; Monoamine Oxidase; Parkinson Disease; Phenethylamines; Selegiline; Tyramine | 1982 |
[Cardiovascular effects of (+)- and (-)-tranylcypromine compared to other monoamine oxidase inhibitors in animal studies (author's transl)].
Topics: Animals; Blood Pressure; Cats; Coronary Circulation; Drug Interactions; Female; Guinea Pigs; Male; Monoamine Oxidase Inhibitors; Myocardial Contraction; Norepinephrine; Pargyline; Selegiline; Stereoisomerism; Tranylcypromine; Tyramine | 1982 |
Monoamine oxidase inhibitors and the cheese effect.
Topics: Animals; Biological Transport; Cheese; Clorgyline; Diet; Drug Interactions; Humans; Hypertension; Intestinal Mucosa; Intestines; Monoamine Oxidase Inhibitors; Rats; Selegiline; Tyramine | 1993 |
Characterization and partial purification of human monoamine oxidase-B expressed in Escherichia coli.
Topics: Blood Platelets; Blotting, Western; Brain; Escherichia coli; Genetic Vectors; Humans; Kinetics; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenethylamines; Recombinant Proteins; Selegiline; Tyramine | 1996 |
Structure-activity studies leading to (-)1-(benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain.
Topics: Amphetamines; Amyloid; Animals; Avoidance Learning; Benzofurans; Brain; Brain Stem; Catecholamines; Cells, Cultured; Electric Stimulation; Hippocampus; Monoamine Oxidase; Neurons; Phenethylamines; Rats; Selegiline; Serotonin; Structure-Activity Relationship; Tryptamines; Tyramine | 2001 |
Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits.
Topics: 2-Hydroxyphenethylamine; Administration, Oral; Adrenergic Uptake Inhibitors; Animals; Blood Pressure; Brain; Clorgyline; Dose-Response Relationship, Drug; Drug Synergism; In Vitro Techniques; Indans; Intestines; Liver; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Rabbits; Selegiline; Serotonin; Tranylcypromine; Tyramine | 2002 |
(-)-Deprenyl inhibits tyramine-induced noradrenaline release, but not tyramine-induced dopamine release or potassium-induced noradrenaline release, from rat brain synaptosomes.
Topics: Animals; Brain; Dopamine; Male; Norepinephrine; Potassium; Rats; Rats, Wistar; Selegiline; Synaptosomes; Tyramine | 2004 |
Contribution of L-3,4-dihydroxyphenylalanine metabolism to the inhibition of gluconeogenesis in rabbit kidney-cortex tubules.
Topics: Alanine; Animals; Aspartic Acid; Caprylates; Depression, Chemical; Dihydroxyacetone; Dopamine; Gluconeogenesis; Glutathione; Glutathione Disulfide; Glycerol; Hydrogen Peroxide; In Vitro Techniques; Kidney Tubules; Levodopa; Male; Phosphoenolpyruvate Carboxykinase (GTP); Pyruvic Acid; Rabbits; Selegiline; Tyramine | 2005 |
Why the transdermal delivery of selegiline (6 mg/24 hr) obviates the need for a dietary restriction on tyramine.
Topics: Administration, Cutaneous; Animals; Depressive Disorder; Diet; Food-Drug Interactions; Guinea Pigs; Humans; Monoamine Oxidase Inhibitors; Selegiline; Tyramine | 2006 |
Psychopharmacology column: why choose selegiline transdermal system for refractory depression?
Topics: Administration, Cutaneous; Antidepressive Agents; Depressive Disorder, Major; Drug Interactions; Humans; Monoamine Oxidase Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Selegiline; Treatment Outcome; Tyramine | 2007 |
Safety of selegiline transdermal system in clinical practice: analysis of adverse events from postmarketing exposures.
Topics: Administration, Cutaneous; Adult; Adverse Drug Reaction Reporting Systems; Aged; Depressive Disorder; Drug Eruptions; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Food-Drug Interactions; Humans; Hypertension; Male; Middle Aged; Monoamine Oxidase Inhibitors; Selegiline; Self-Injurious Behavior; Tyramine; United States | 2012 |
Monoamine oxidase inhibitors revisited: what you should know.
Topics: Antidepressive Agents; Depressive Disorder; Drug Therapy, Combination; Humans; Isocarboxazid; Monoamine Oxidase Inhibitors; Phenelzine; Selegiline; Tranylcypromine; Tyramine | 2013 |
Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study.
Topics: Animals; Biocatalysis; Carbamates; Coumarins; Dose-Response Relationship, Drug; Humans; Hydrogen Peroxide; Mice; Models, Molecular; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; Protein Binding; Protein Structure, Tertiary; Selegiline; Substrate Specificity; Tyramine | 2013 |
The evaluation of N-propargylamine-2-aminotetralin as an inhibitor of monoamine oxidase.
Topics: Humans; Indans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Parkinson Disease; Propylamines; Selegiline; Tetrahydronaphthalenes; Tyramine | 2022 |